Post-market Reviews of Chronic Obstructive Pulmonary Disease (COPD) medicines and Ezetimibe – Public Consultation
Page last updated: 8 March 2016
The public submission process is now open for the Post-market Reviews of:
- Chronic Obstructive Pulmonary Disease medicines; and
- Ezetimibe.
Interested organisations and individuals are invited to provide a submission addressing the Reviews’ Terms of Reference. To make a submission please go to the relevant Public Consultation page:
The public submission process will be open for 7 weeks and will close at 5pm Friday, 22 April 2016. The guidance to the page limit has been removed from the PBS website call for submissions with respect to the Post Market Reviews of Ezetimbe and COPD medicines.
Further information on the Reviews are available on the COPD Review or the Ezetimibe Review web pages.
